Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), announced that its Chief Financial Officer, Jill McConnell, will participate in a virtual fireside chat hosted by Elizabeth Anderson, senior managing director at Evercore ISI.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), announced that its Chief Financial Officer, Jill McConnell, will participate in a virtual fireside chat hosted by Elizabeth Anderson, senior managing director at Evercore ISI. The event is scheduled for Thursday, June 20, 2024, at 2:00 pm ET, and will last for 30 minutes. Registration is required for the live event, and a replay will be available on the Fortrea Investor Relations website after the event.
Details
News Market Reaction – FTRE
The recorded move for FTRE in the trading session of this news was +2.53%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., June 19, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chief Financial Officer Jill McConnell will participate in a virtual fireside chat hosted by Elizabeth Anderson, senior managing director at Evercore ISI, to discuss Fortrea’s business on Thursday, June 20, 2024 at 2:00 pm ET.
Webcast and Replay Information
Registration for the live event is required here. The event is scheduled for 30 minutes. A replay will be available by accessing the Fortrea Investor Relations website after the conclusion of the event.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea Contacts:
Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.